Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Allison P. Jacob"'
Autor:
Colette Owens, Allison P. Jacob, Jade Ruiters, Sidney Sechio, Audrey Hamilton, Clare Grieve, Puja Chadha, Mikhail Roshal, Tak Takvorian, Daneal Portman, Anthony R. Mato, Krista J Scorsune, Jason Carter, Ahmet Dogan, Lauren Ramos, Ai Ni, Natascha Nolet, Juliana M.L. Biondo, Jane Huang, Ephraim P. Hochberg, Anita Kumar, Stephanie Hughes, Morgan Choma, M. Lia Palomba, Rosalba Martignetti, Ariela Noy, Jeffrey A. Barnes, Meghan C. Thompson, P. Connor Johnson, Jeremy S. Abramson, Connie Lee Batlevi, Julia M Lynch, Qun Wu, Chaya Friedman, Erel Joffe, Joanna Mi, Brianne McGree, Elizabeth Simkins, Venkatraman E. Seshan, Matthew J. Matasar, Kelsey Flaherty, Omar Abdel-Wahab, Lindsey E. Roeker, Andrew D. Zelenetz, Jacob D. Soumerai, Neena Mahajan
Publikováno v:
The Lancet Haematology. 8:e879-e890
Summary Background We hypothesised that combining zanubrutinib with obinutuzumab and venetoclax (BOVen) as an initial therapy for chronic lymphocytic leukaemia and small lymphocytic lymphoma would lead to high rates of undetectable minimal residual d
Autor:
Ilan R. Kirsch, Juliana Craig, Frederick L. Locke, Michael D. Jain, Allison P. Jacob, Lik Wee Lee, Jay Y. Spiegel, Matthew J. Frank, Ali Bukhari, Gursharan K. Claire, David B. Miklos, Katherine A. Kong, Aaron P. Rapoport, Erin Dean, Nasheed Hossain, Chelsea D. Mullins, Crystal L. Mackall, Saurabh Dahiya
Publikováno v:
J Clin Oncol
PURPOSE Although the majority of patients with relapsed or refractory large B-cell lymphoma respond to axicabtagene ciloleucel (axi-cel), only a minority of patients have durable remissions. This prospective multicenter study explored the prognostic
Autor:
Allison P. Jacob, Cindy Varga, Mariateresa Fulciniti, Nikhil C. Munshi, Shayna Sarosiek, Vaishali Sanchorawala
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-4 (2021)
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-4 (2021)
Autor:
A. Park, T. Willis, Kurt S. Bantilan, Malek Faham, Audrey Hamilton, John F. Gerecitano, S.F. Schoninger, Carol S. Portlock, Paul A. Hamlin, Allison P. Jacob, Craig S. Sauter, K.A. Kong, M. Matasar, Ariela Noy, Gary A. Ulaner, Anita Kumar, Craig H. Moskowitz, Carla Casulo, Ravinder K. Grewal, Andrew D. Zelenetz, Maria Lia Palomba, Anas Younes
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:230-237.e12
Background Minimal residual disease (MRD) monitoring has been used to identify early molecular relapse and predict clinical relapse in mantle cell lymphoma (MCL). Few published data exist in MCL on the performance of next-generation sequencing–base
Autor:
Charles E. Wood, Kathy Rohrbach, Hermina Borgerink, Daniel Branstetter, Li-Ya Huang, Allison P. Jacob, William C. Dougall, Thomas C. Register, J. Mark Cline
Publikováno v:
Breast Cancer Research : BCR
Introduction Menopausal hormone therapies vary widely in their effects on breast cancer risk, and the mechanisms underlying these differences are unclear. The primary goals of this study were to characterize the mammary gland transcriptional profile